Abstract
Macrophages are a key component of the tumor microenvironment (TME). Blocking Clever-1, a molecule expressed in M2-like macrophages, unleashed macrophage and T-cell–mediated antitumor immunity. Myeloid checkpoints including Clever-1 hold promise as alternative or complementary immunotherapy strategies. See related article by Viitala et al., p. 3289
Funding Information
  • Associazione Italiana per la Ricerca sul Cancro (IG 19014, 1000 9962, 21147,, IG 20269)